Lamotrigine Tablet
Product Images NDC 43063-238

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 43063-238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063238 Label (43063238)

This text contains information about a medication called lamoTRIgine in different dosages and quantities. It provides details about the manufacturer, the lot numbers, and expiration dates. Additionally, the text instructs to call a doctor for advice about side effects and encourages reporting any side effects to the FDA. However, the text also contains some unclear and unrelated parts, which make it difficult to provide a full context.*

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 01

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 02

FDA Label Image

5a15187f B147 4147 A4ef 0e3e5de73cb6 03

FDA Label Image

708290c4 B959 47cc 95a1 38a6270297e5 1119 2

This appears to be a product label for Tamotrigine tablets in different strengths (25mg, 100mg, 150mg, and 200mg). The text also includes the name "Tobiet Serengh" and the term "dimensional drawing", which may be referring to a visual representation of the tablet's size and shape.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.